CADRENAL THERAPEUTICS INC (CVKD) Stock Analyst Ratings
NASDAQ:CVKD - Nasdaq - US1276362076 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to CVKD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 36.38. This target is 149.01% above the current price.
CVKD was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CVKD.
In the previous month the buy percentage consensus was at a similar level.
CVKD was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-18 | Noble Capital Markets | Initiate | Outperform |
| 2023-11-20 | HC Wainwright & Co. | Initiate | Buy |